Menopausal estrogen therapy predicts better nocturnal oxyhemoglobin saturation

Maturitas

Volumn 55, Issue 3, 2006, Pages 255-263

  Saaresranta, Tarja ^a,b   Polo Kantola, Päivi ^a,b   Virtanen, Irina ^a,b   Vahlberg, Tero ^a   Irjala, Kerttu ^c   Polo, Olli ^a,d  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c Mehilainen Oy   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Breathing; Estrogen; Hypoxia; Menopause; Sleep apnea; Sleep disordered breathing

Indexed keywords

ESTRADIOL; ESTROGEN; OXYHEMOGLOBIN;

ADULT; AGED; ARTERIAL OXYGEN TENSION; ARTICLE; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; ESTRADIOL BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MENOPAUSE; NIGHT; NORMAL HUMAN; OXYGENATION; POSTMENOPAUSE; SLEEP APNEA SYNDROME; SLEEP DISORDERED BREATHING;

BODY MASS INDEX; CIRCADIAN RHYTHM; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MENOPAUSE; MIDDLE AGED; OXIMETRY; OXYHEMOGLOBINS; POLYSOMNOGRAPHY; PROSPECTIVE STUDIES;

EID: 33748697403     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2006.03.007     Document Type: Article

References (52)

1. White D.P., Douglas N.J., Pickett C.K., et al. Hypoxic ventilatory response during sleep in normal premenopausal women. Am Rev Respir Dis 126 (1982) 530-533
2. Saaresranta T., Polo-Kantola P., Irjala K., et al. Respiratory insufficiency in postmenopausal women: sustained improvement of gas exchange with short-term medroxyprogesterone acetate. Chest 115 (1999) 1581-1587
3. Saaresranta T., Polo-Kantola P., Rauhala E., et al. Medroxyprogesterone in postmenopausal females with partial upper airway obstruction during sleep. Eur Respir J 18 (2001) 989-995
4. Saaresranta T., Aittokallio T., Polo-Kantola P., et al. Effect of medroxyprogesterone on inspiratory flow shapes during sleep in postmenopausal women. Respir Physiol Neurobiol 134 (2003) 131-143
5. Popovic R.M., and White D.P. Upper airway muscle activity in normal women: influence of hormonal status. J Appl Physiol 84 (1998) 1055-1062
6. Bixler E.O., Vgontzas A.N., Lin H.-M., et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med 163 (2001) 608-613
7. Shahar E., Redline S., Young T., et al. Hormone-replacement therapy and sleep-disordered breathing. Am J Respir Crit Care Med 167 (2003) 1186-1192
8. Netzer N.C., Eliasson A.H., and Strohl K.P. Women with sleep apnea have lower levels of sex hormones. Sleep Breath 7 (2003) 25-29
9. Shoham Z., and Kopernik G. Tools for making correct decisions regarding hormone therapy. Part I: Background and drugs. Fertil Steril 81 (2004) 1447-1457
10. Kopernik G., and Shoham Z. Tools for making correct decisions regarding hormone therapy. Part II. Organ response and clinical applications. Fertil Steril 81 (2004) 1458-1477
11. Behan M., Zabka A.G., Thomas C.F., et al. Sex steroid hormones and the neural control of breathing. Respir Phys Neurobiol 136 (2003) 249-263
12. Polo-Kantola P., Rauhala E., Helenius H., et al. Breathing during sleep in menopause: a randomized, controlled, cross-over trial with estrogen therapy. Obstet Gynecol 102 (2003) 68-75
13. Plass E.D., and Oberst F.W. Respiration and pulmonary ventilation in normal nonpregnant, pregnant, and puerperal women with an interpretation of acid-base balance during normal pregnancy. Am J Obstet Gynecol 35 (1938) 441-452
14. 2 and in base excess during the menstrual cycle. Respir Physiol 26 (1976) 157-161
15. White D.P., Douglas N.J., Pickett C.K., et al. Sexual influence on the control of breathing. J Appl Physiol 54 (1983) 874-879
16. Schoene R.B., Robertson H.T., Pierson D.J., et al. Respiratory drives and exercise in menstrual cycles of athletic and non-athletic women. J Appl Physiol 50 (1981) 1300-1305
17. Skatrud J.B., Dempsey J.A., and Kaiser D.G. Ventilatory response to medroxyprogesterone acetate in normal subjects: time course and mechanism. J Appl Physiol 44 (1978) 939-944
18. Zwillich C.W., Natalino M.R., Sutton F.D., et al. Effects of progesterone on chemosensitivity in normal men. J Lab Clin Med 92 (1978) 262-269
19. Regensteiner J.G., Woodard W.D., Hagerman D.D., et al. Combined effects of female hormones and metabolic rate on ventilatory drives in women. J Appl Physiol 66 (1989) 808-813
20. Brodeur P., Mockus M., McCullough R., et al. Progesterone receptors and ventilatory stimulation by progestin. J Appl Physiol 60 (1986) 590-595
21. Hosenpud J.D., Hart M.V., Morton M.J., et al. Progesterone-induced hyperventilation in the guinea pig. Respir Physiol 52 (1983) 259-264
22. Leavitt W.W., and Blaha G.C. An estrogen-stimulated, progesterone-binding system in the hamster uterus and vagina. Steroids 19 (1972) 263-274
23. Tatsumi K., Pickett C.K., Jacoby C.R., et al. Role of endogenous female hormones in hypoxic chemosensitivity. J Appl Physiol 83 (1997) 1706-1710
24. Saaresranta T., and Polo O. Hormones and breathing. Chest 122 (2002) 2165-2182
25. Saaresranta T., and Polo O. Sleep-disordered breathing and hormones. Eur Respir J 22 (2003) 161-172
26. Shugrue P.J., Lane M.V., and Merchemthaler I. Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J Comp Neurol 388 (1997) 507-525
27. Holtman J.R.J. Immunohistochemical localization of serotonin- and substance P-containing fibers around respiratory muscle motoneurons in the nucleus ambiguus of he cat. Neuroscience 26 (1988) 169-178
28. Li Y.Q., Takada M., and Mizuno N. The sites of origin of serotoninergic afferent fibers in the trigeminal motor, facial, and hypoglossal nuclei in the rat. Neurosci Res 17 (1993) 307-313
29. Manaker S., and Tiscler L.J. Origin of serotonergic afferents to the hypoglossal nucleus in the rat. J Comp Neurol 334 (1993) 466-476
30. Erickson J.T., and Millhorn D.E. Hypoxia and electrical stimulation of the carotid sinus nerve induce Fos-like immunoreactivity within catecolaminergic and serotoninergic neurons of the rat brainstem. J Comp Neurol 348 (1994) 161-182
31. Kinkead R., Bach K.B., Johnson S.M., et al. Plasticity in respiratory motor control: intermittent hypoxia and hypercapnia activate opposing serotonergic and noradrenergic modulatory systems. Comp Biochem Physiol A Mol Integr Physiol 130 (2001) 207-218
32. Teppema L.J., Veening J.G., Kranenburg A., et al. Expression of c-fos in the rat brainstem after exposure to hypoxia and to normoxic and hyperoxic hypercapnia. J Comp Neurol 388 (1997) 169-190
33. Berger A.J., Bayliss D.A., and Viana F. Modulation of neonatal rat hypoglossal motoneuron excitability by serotonin. Neurosci Lett 143 (1992) 164-168
34. Lindsay A.D., and Feldman J.L. Modulation of respiratory activity of neonatal rat phrenic motoneurons by serotonin. J Physiol Lond 461 (1993) 213-233
35. Arita H., Ichikawa K., and Sakamoto M. Serotonergic cells in nucleus raphe pallidus provide tonic drive to posterior cricoarytenoid motoneurons via 5-hydroxytryptamine receptors in cats. Neurosci Lett 197 (1995) 113-116
36. Hilaire G., Bou C., and Monteau R. Serotonergic modulation of central respiratory activity in the neonatal mouse: an vitro study. Eur J Pharmacol 329 (1997) 115-120
37. Di Pasquale E., Lindsay A., Feldman J., et al. Serotonergic inhibition of phrenic motoneuron activity: an vitro study in neonatal rat. Neurosci Lett 230 (1997) 29-32
38. Blum I., Vered Y., Lifshitz A., et al. The effect of estrogen replacement therapy on plasma serotonin and catecholamines of postmenopausal women. Isr J Med Sci 32 (1996) 1158-1162
39. Biver F., Lotstra F., Monclus M., et al. Sex differences in 5HT2 receptor in the living human brain. Neurosci Lett 204 (1996) 25-28
40. Rubinow D.R., Schmidt P.J., and Roca C.A. Estrogen-serotonin interactions:implications for affective regulation. Biol Psychiatry 44 (1998) 839-850
41. Moses E.L., Drevets W.C., Smith G., et al. Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: a PET study. Biol Psychiatry 48 (2000) 854-860
42. Keefe D.L., Watson R., and Naftolin F. Hormone replacement therapy may alleviate sleep apnea in menopausal women: a pilot study. Menopause 6 (1999) 196-200
43. Cistulli P.A., Barnes D.J., Grunstein R.R., et al. Effect of short term hormone replacement in the treatment of obstructive sleep apnoea in postmenopausal women. Thorax 49 (1994) 699-702
44. Manber R., Kuo T.F., Cataldo N., et al. The effects of hormone replacement therapy on sleep-disordred breathing in postmenopausal women: a pilot study. Sleep 26 (2003) 163-168
45. Phillipson E.A., and Kozar L.F. Effect of aging on metabolic respiratory control in sleeping dogs. Ann Rev Respir Dis 147 (1993) 1521-1525
46. Nishimura M., Yamamoto M., Yoshioka A., et al. Longitudinal analysis of respiratory chemosensitivity in normal subjects. Am Rev Respir Dis 143 (1991) 1278-1281
47. Chandler M.H.H., Schuldheisz S., Phillips B.A., and Muse K.N. Premenstrual asthma: the effects of estrogen on symptoms, pulmonary function, and beta 2-receptors. Pharmacotherapy 17 (1997) 224-234
48. Tan K.S., McFarlane L.C., and Lipworth B.J. Modulation of airway reactivity and peak flow variability in asthmatics receiving the oral contraceptive pill. Am J Respir Crit Care Med 155 (1997) 1273-1277
49. Lieberman D., Kopernik G., Porath A., et al. Subclinical worsening of bronchial asthma during estrogen replacement therapy in asthmatic postmenopausal women. Maturitas 21 (1995) 153-157
50. Barr R.G., Wentowski C.C., Grodstein F., et al. Prospective study of postmenopausal hormone use and newly diagnosed asthma and chronic obstructive pulmonary disease. Arch Intern Med 164 (2004) 379-386
51. Tsai W.H., Flemons W.W., Whitelaw W.A., et al. A comparison of apnea-hypopnea indices derived from different definitions of hypopnea. Am J Respir Crit Care Med 159 (1999) 43-48
52. Vázquez J.-C., Tsai W.H., Flemons W.W., et al. Automated analysis of digital oximetry in the diagnosis of obstructive sleep apnoea. Thorax 55 (2000) 302-307